Paul Hudson is the founder of Translate Bio. Translate Bio has raised $136M in total funding. Latest round: Series C. Backed by Atlas Venture.
Paul Hudson is the Chief Executive Officer of Sanofi. Under his leadership, Sanofi acquired Translate Bio, an mRNA therapeutics company, for approximately $3.2 billion. This acquisition aimed to accelerate Sanofi's deployment of mRNA technology across vaccines and therapeutics development.
Full founder directory · Investor directory · Company funding database · Fundraising library